IP Library › Granted Patent US 12,559,796
Granted Patent B2
US 12,559,796 · App. 17/860,036 · Granted Feb 24, 2026

Fluorescence energy transfer-based single molecule/ensemble DNA sequencing by synthesis

Inventors: Jingyue Ju (Englewood Cliffs, NJ); Shiv Kumar (Belle Mead, NJ); James J. Russo (New York, NY); Steffen Jockusch (New York, NY); Zengmin Li (Flushing, NY); Xiaoxu Li (New York, NY); Sergey M. Kalachikov (Bronx, NY); Irina Morozova (Bronx, NY)
Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
C12Q1/6869C07H19/10C07H19/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,559,796
App. No.
17/860,036
Granted
Feb 24, 2026
Kind
B2
Abstract

This invention provides nucleotide analogues each of which comprises a tag comprising one or more Forster resonance energy transfer (FRET) acceptor fluorophores, a nucleotide polymerase having one or more FRET donor fluorophores, and methods for sequencing single-stranded DNA.

Claims (37)

1 . A method for determining the nucleotide sequence of a single-stranded DNA comprising:

a) contacting a plurality of copies of the single-stranded DNA, wherein each single-stranded DNA has a primer hybridized to a portion thereof, a polymerase, and a nucleotide analogue, under conditions permitting the polymerase to form a ternary complex with the single-stranded DNA having the primer hybridized thereto and the nucleotide analogue, wherein the nucleotide analogue has a base that is complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleoside residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, wherein the nucleotide analogue is not incorporated by the polymerase onto the primer, and wherein the nucleotide analogue has multiple fluorescent dyes attached thereupon;

b) identifying the nucleotide analogue in the ternary complex by detecting the fluorescent emission;

c) contacting the ternary complex with 3′-0 blocked nucleotide reversible terminators under conditions permitting the polymerase to catalyze incorporation onto the primer of a 3′-O-blocked nucleotide reversible terminator complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleotide residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, thereby replacing the nucleotide analogue in the ternary complex;

d) cleaving the 3′-O-blocking moiety of the incorporated 3′-O blocked nucleotide reversible terminator, thereby resulting in a 3′-OH; and

e) iteratively performing steps a) through d) for each nucleotide residue of the single-stranded DNA to be sequenced so as to thereby determine the sequence of the single-stranded DNA.

2 . The method of claim 1 , wherein the polymerase has attached, incorporated, and/or conjugated fluorescence donor molecules, wherein the fluorescence donor molecules are Forster Resonance Energy Transfer (FRET) donors, and the multiple fluorescent dyes on the nucleotide analogue are corresponding FRET acceptors.

3 . The method of claim 2 , wherein the acceptor dye comprises 1, 2, or 3 organic fluorophores.

4 . The method of claim 3 , wherein the organic fluorophore is a cyanine dye, a rhodamine dye, fluorescein, acridine, coumarin, red-fluorescent dye, GFP, rhodol, resorfuin, N, N,N′, N′-tetramethyl-6-carboxyrhodamine, or a plurality of any of the foregoing.

5 . The method of claim 1 , wherein the primer, single-stranded DNA, or polymerase are bound to a magnetic bead or the surface of a fluidic chamber.

6 . The method of claim 5 , wherein the primer, single-stranded DNA, or polymerase bound to the magnetic bead or surface are modified with one of amino, sulfhydryl, or biotin moieties.

7 . The method of claim 1 , wherein the method is performed simultaneously on a plurality of single-stranded DNAs.

8 . The method of claim 2 , wherein when the ternary complex is formed, the FRET donors and the FRET acceptors are less than 10 nm from each other.

9 . The method of claim 2 , wherein the FRET donors and the FRET acceptors are between 2 nm-4 nm from each other.

10 . A method for determining the nucleotide sequence of a single-stranded DNA comprising:

a) contacting a plurality of copies of the single-stranded DNA, wherein each single-stranded DNA has a primer hybridized to a portion thereof, a polymerase, and 4 nucleotide analogues having the base of A, T, C and G, respectively, under conditions permitting the polymerase to form a ternary complex with the single-stranded DNA having the primer hybridized thereto and one of the nucleotide analogues, wherein said nucleotide analogue has a base that is complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleoside residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, wherein said nucleotide analogue is not incorporated by the polymerase onto the primer, and wherein each nucleotide analogue has multiple fluorescent dyes with distinct emission attached thereto;

b) identifying the nucleotide analogue in the ternary complex by detecting its unique fluorescent emission;

c) contacting the ternary complex with 3′-0 blocked nucleotide reversible terminators under conditions permitting the polymerase to catalyze incorporation onto the primer of a 3′-O-blocked nucleotide reversible terminator complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleotide residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, thereby replacing the nucleotide analogue in the ternary complex;

d) cleaving the 3′-O-blocking moiety of the incorporated 3′-0 blocked nucleotide reversible terminator, thereby resulting in a 3′-OH; and

e) iteratively performing steps a) through d) for each nucleotide residue of the single-stranded DNA to be sequenced so as to thereby determine the sequence of the single-stranded DNA.

11 . The method of claim 10 , wherein the polymerase has attached, incorporated, and/or conjugated fluorescence donor molecules, wherein the fluorescence donor molecules are Forster Resonance Energy Transfer (FRET) donors, and the multiple fluorescent dyes on the nucleotide analogue are corresponding FRET acceptors.

12 . The method of claim 11 , wherein the FRET acceptors dye comprise 1, 2, or 3 organic fluorophores.

13 . The method of claim 12 , wherein the organic fluorophore is a cyanine dye, a rhodamine dye, fluorescein, acridine, coumarin, red-fluorescent dye, GFP, rhodol, resorfuin, N, N,N′, N′-tetramethyl-6-carboxyrhodamine, or a plurality of any of the foregoing.

14 . The method of claim 10 , wherein the primer, single-stranded DNA, or polymerase are bound to a magnetic bead or the surface of a fluidic chamber.

15 . The method of claim 14 , wherein the primer, single-stranded DNA, or polymerase bound to the magnetic bead or surface are modified with one of amino, sulfhydryl, or biotin moieties.

16 . The method of claim 10 , wherein the method is performed simultaneously on a plurality of single-stranded DNAs.

17 . The method of claim 11 , wherein prior to step a), the single-stranded DNA is amplified using emulsion PCR thereby resulting in the plurality of copies of single-stranded DNAs.

18 . The method of claim 11 , wherein when the ternary complex is formed, the FRET donors and the FRET acceptors are less than 10 nm from each other.

19 . The method of claim 11 , wherein the FRET donors and the FRET acceptors are between 2 nm-4 nm from each other.

20 . A method for determining the nucleotide sequence of a single-stranded DNA comprising:

a) contacting a plurality of copies of single-stranded DNA, wherein each single-stranded DNA has a primer hybridized to a portion thereof, a polymerase, and 4 nucleotide analogues, wherein each of the 4 nucleotide analogues has the following structure:

wherein the base is adenine, guanine, cytosine, uracil, thymine, or a derivative thereof, wherein X is CH 2 , NH, CHF, or CF 2 , wherein n is 0, 1, 2, 3, or 4, wherein the acceptor dye is 2 or 3 fluorophores,

under conditions permitting the polymerase to form a ternary complex with the single-stranded DNA having the primer hybridized thereto and one of the nucleotide analogues, wherein said nucleotide analogue has a base that is complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleoside residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, wherein said nucleotide analogue is not incorporated by the polymerase onto the primer, and wherein each nucleotide analogue has fluorophores with distinct emission attached thereto;

b) identifying the nucleotide analogue in the ternary complex by detecting its unique fluorescent emission;

c) contacting the ternary complex with 3′-O blocked nucleotide reversible terminators under conditions permitting the polymerase to catalyze incorporation onto the primer of a 3′-O-blocked nucleotide reversible terminator complementary to a nucleotide residue of the single-stranded DNA which is immediately 5′ to a nucleotide residue of the single-stranded DNA hybridized to the 3′ terminal nucleotide residue of the primer, thereby replacing the nucleotide analogue in the ternary complex;

d) cleaving the 3′-O-blocking moiety of the incorporated 3′-0 blocked nucleotide reversible terminator, thereby resulting in a 3′-OH; and

e) iteratively performing steps a) through d) for each nucleotide residue of the single-stranded DNA to be sequenced so as to thereby determine the sequence of the single-stranded DNA.

Continuity (2)
Division 16091442 · Oct 4, 2018
Related Publication 20220364167A1 · Nov 17, 2022
References Cited (16)
US 8314216B2 · Hardin et al. · 2012 [cited by applicant]
US 8603741B2 · Emig et al. · 2013 [cited by applicant]
US 8927212B2 · Kong et al. · 2015 [cited by applicant]
US 11384391B2 · Ju · 2022 [cited by examiner]
US 20100167277A1 · Harper · 2010 [cited by applicant]
US 20130264207A1 · Ju et al. · 2013 [cited by applicant]
US 20140206550A1 · Bjornson et al. · 2014 [cited by applicant]
US 20140234853A1 · Vander Horn et al. · 2014 [cited by applicant]
WO WO2006035207A2 · 2006 [cited by applicant]
Shao et al. “Emulsion PCR: A High Efficient Way of PCR Amplification of Random DNA Libraries in Aptamer Selection” PLoS ONE, Sep. 2011, vol. 6, Issue 9, e24910, pp. 1-7. (Year: 2011). [cited by examiner]
Communication pursuant to Article 94(3), issued Mar. 30, 2021 by the European Patent Office in connection with European Application Publication No. EP 17779618.2-1118. [cited by applicant]
Second Office Action, issued Mar. 16, 2021 by the China National Intellectual Property Administration in connection with Chinese Application No. 201780034786.2. [cited by applicant]
Response to Second Office Action, filed May 28, 2021 to the China Intellectual Property Administration in connection with Chinese Application No. 201780034768.2 in Chinese, and English draft thereof. [cited by applicant]
Communication forwarding Extended European Search Report, issued by the European Patent Office on Jan. 8, 2020, concerning counterpart European Patent Application No. 17779618.2. [cited by applicant]
International Search Report issued Aug. 7, 2017 in connection with PCT International Application No. PCT/US2017/025850. [cited by applicant]
Written Opinion of the International Searching Authority issued Aug. 7, 2017 in connection with the PCT International Application No. PCT/US2017/025850. [cited by applicant]